Cherry TV Land,

A few months ago, I answered a question regarding ‘Female Viagra.’ In the post, I briefly explained why Sildenafil (Viagra) has not proven to be effective for most women. (To read the article, click here.) I’m writing now as an update on the ‘Female Viagra’ debate. The pharmaceutical company Boehringer Ingelheim is currently marketing a drug called Flibanserin (a type of anti-depressant) as a treatment for Hypoactive Sexual Desire Disorder (HSDD) in women. Since past research has tried to link women’s low libido with hormonal problems [anybody remember the Intrinsa testosterone patch that didn’t make it?], HSDD as a ‘head problem’ is somewhat novel. Still, one must ask herself if it’s all worth it. Flibanserin would need to be taken daily for 3-6 weeks before any effect would be noticed (plus continuously after.) Also, long-term safety information is still lacking. On the plus side, it does seem that Flibanserin could encourage further patient-clinician dialogue regarding sexual health and satisfaction for women. Let’s just hope the conversation incorporates some of the other countless possible explanations for changes in a woman’s sexual desire.

What are your feelings on a ‘Female Viagra?’ Should women’s sexual problems continue to be medicalized? Leave a comment and share your thoughts!

-Little Cherry